UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
For the fiscal year ended
For the transition period from _______________ to __________
Commission file number:
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
(Address of principal executive offices)
(Registrant’s telephone number, including area code)
_______________________________________
(Former name or former address, if changed since last report).
Securities registered pursuant to Section 12(b) of the Act:
| Title of Class | Trading Symbol(s) | Name of each exchange on which registered/ | ||
| OTC Markets: PINK |
Securities registered pursuant to Section 12(g) of the Act:
Common Stock
(Title of Class)
Indicate by check mark if the registrant is a
well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐
Indicate by check mark if the registrant is not
required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐
Indicate by check mark whether the registrant
(1) has filed all reports to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for
the past 90 days.
Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulations S-T (232.405 of
this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Indicate by check mark whether the registrant is a large accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in rule 12b-2 of the Exchange Act.
| Large accelerated filer ☐ | Accelerated filer ☐ | |
| Smaller reporting company |
||
| Emerging Growth Company |
If an emerging growth company, indicate by check
mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes ☐ No ☒
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐
Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Act): Yes ☐
The aggregate market value of the voting stock
held by non-affiliates of the registrant, based upon the closing sale price of the registrant’s common stock on March 30, 2023,
was $
As of March 30, 2023, the Registrant had issued and outstanding shares of common stock.
HFactor, Inc.
FORM 10-K
TABLE OF CONTENTS
| i |
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Annual Report on Form 10-K, with the accompanying Financial Statements and Notes to Financial Statements contain forward-looking statements that discuss, among other things, future expectations and projections regarding future developments, operations and financial conditions. All forward-looking statements are based on management’s existing beliefs about present and future events outside of management’s control and on assumptions that may prove to be incorrect. Words such as “expects”, “intends”, “anticipates”, “believes”, “estimates”, “assumes”, “projects” and similar expressions are intended to identify such forward-looking statements. You should not rely solely on the forward-looking statements and should consider all uncertainties and risks throughout this Annual Report on Form 10-K, including those described under “Risk Factors”. These statements are based on information currently available, and we undertake no obligation to update any forward-looking statement as circumstances change.
When this report uses the words “we,” “us,” “our,” “HFactor”, or the “Company,” they refer to HFactor, Inc.
| ii |
PART I
ITEM 1. BUSINESS
Company Overview and Plan of Operation
HFactor, Inc. ("HFactor", "Ficaar", the "Company", "we", "us") was incorporated in July 2001 in the State of Georgia under the name OwnerTel, Inc. The name of the Company was changed to Ficaar, Inc. in December of 2007. Effective November 8, 2021, the Company's name was changed to HFactor, Inc.
In August 2012, certain shareholders of the Company representing a majority of the issued and outstanding stock of the Company entered into an agreement and consummated such agreement with Sneaker Charmz, Inc. ("Sneaker Charmz"), a Delaware corporation, whereby 72,020,000 shares of common stock were assigned by the Shareholders to Sneaker Charmz. Thereafter, Sneaker Charmz, and David Cicalese consummated a transaction where the shares of common stock owned by Sneaker Charmz were transferred and assigned to Mr. Cicalese, and Mr. Cicalese's ownership of Sneaker Charmz to the Company. Thus, Sneaker Charmz became a wholly owned subsidiary of the Company and Mr. Cicalese owned 85% of the total issued and outstanding common stock of the Company.
In January 2014, Mr. Cicalese, President, a member of the Board of Directors, and the majority shareholder of the Company, contributed 100 shares, representing all of the issued and outstanding equity of Precious Holdings, Inc., a Delaware corporation, to the Company. Thus, Precious Holdings, Inc. became a wholly owned subsidiary of the Company.
On November 16, 2014, in exchange for 110,000 shares of our common stock, we acquired 100% of the outstanding common stock of Standard Canna, Inc. ("Standard"), a Florida corporation, and its wholly owned subsidiaries, Standard Cultivation Systems, Inc., a Colorado corporation, and Standard Property Group, Inc., a California corporation. This acquisition was pursuant to a Transfer Agreement by and among the Company and Jonas Zetzel, sole shareholder of Standard.
On July 28, 2015, the Company transferred its ownership in Sneaker Charmz to David Cicalese, our sole officer and director and majority shareholder, in exchange for 42,000,000 shares of our common stock, which reduced Mr. Cicalese's share ownership of the Company to 30,020,000 shares of Company Common Stock. In July 2015, the Board of Directors and shareholders representing a majority of the issued and outstanding common stock of the Company appointed Dawn Cames as President of the Company and a member of its Board of Directors. In connection with Ms. Cames’ appointment, she was issued 1,300,000 shares of Company common stock.
On May 28, 2021, David Cicalese entered into an agreement with Gail Levy whereby Cicalese agreed to sell 29,900,000 shares, representing a majority interest in the Company, to Levy. Acting as the majority shareholder of the Company, Levy then caused to enter into an Agreement and Plan of Merger (the "Merger Agreement") between the Company, FCAA Merger Sub I, Inc. ("Merger Sub"), a Delaware corporation and wholly owned subsidiary of the Company, and HyEdge, Inc. ("Target" or "HyEdge"), a Delaware corporation, wherein Merger Sub and Target would merge, with Target surviving the transaction as a wholly owned subsidiary of (the "Merger"). The Merger Agreement was executed on August 6, 2021, and the Merger closed on August 9, 2021. The Merger effected a change in control and was accounted for as a "reverse acquisition" whereby Target is the accounting acquiror for financial statement purposes. Accordingly, for all periods subsequent to the Closing Date, the financial statements of the Company reflect the historical financial statements of HyEdge and any operations of the Company subsequent to the Merger.
Immediately following the Merger, the business of HyEdge became our business.
| 1 |
Overview
The Company operates primarily through HyEdge, its wholly owned subsidiary. HyEdge was created by Gail Levy, HyEdge's founder and CEO. Gail is a successful serial entrepreneur who was looking for a new product that could alleviate the toxic side effects of the cancer chemotherapeutic drugs that had riddled a dear friend. As she researched the properties of hydrogen water, she became more and more enthralled by its potential.
Ms. Levy felt she could honor her friend by making hydrogen water immaculate, effective, and accessible to everyone. Enlivened by this mission, she collected a team of experts to help her engineer a natural process to combine hydrogen with water with zero impurities and optimal impact. In 2017, she launched her flagship product through retail and ecommerce channels.
HFactor was developed and is manufactured by a team of experts in the U.S. and utilizes a patented chemical-free and magnesium-free process to infuse free hydrogen into its water. Its award winning, environmentally friendly ergonomic pouch keeps the hydrogen potent and pure and makes it extremely portable.
HFactor's anti-inflammatory and antioxidant benefits appeal to a wide population across every age group, positioning HFactor to capture a significant share in an expanding market. The global market for bottled water is projected to reach $215B by 2025. HFactor has demonstrated significant market traction, with $2.87M sales in 2020, 30M+ followers across Social Media channels.
The quality of our product is achieved through a proprietary manufacturing process. A reverse osmosis filtering system and patent-protected infusion process ensures efficacy, purity, and taste. The efficacy of hydrogen water is backed by over 1,000 published studies demonstrating that hydrogen positively impacts fitness, health, lifestyle, recovery, and wellness.
Our sales strategy involves a diversified, multi-channel approach. Our products are currently on shelves in approximately 5,000+ retail stores across 20 chains in addition to our growing e-commerce presence. Our company prides itself on having a low carbon footprint, primarily due to our eco-conscious packaging.
Mission Statement
To build a brand and corporate culture that, at its essence, exhibits strength in oneself and in one's community. We promote a foundation of "doing well by doing good". This foundation enables HFactor to produce and distribute the highest quality "better for you" consumer products that are conscious to the community, mind, body, and the environment.
The Worldwide Health and Fitness Movement
Consumers are looking for a go-to hydration option that provides additional functional benefits without sugar or caffeine. The worldwide health and fitness movement is just beginning. More and more people are realizing the importance of what you put in your body and how you maintain it. On a greater scale, consumers are looking for brands that have removed artificial ingredients. This has led to a recent increase in contracts from major retailers and distributors in the US that should result in a significant increase to the Company's retail presence throughout 2022 and 2023.
Maintaining Relevance in a Digital World
HFactor has found success by establishing beneficial relationships with target-aligned influencers and sponsoring a multitude of events and activities. We have built organic relationships with athletes and influencers in the fitness space to drive awareness, education, and ecommerce. To solidify HFactor in the fitness space, we have had a strong presence at many sports and fitness events as participating sponsor, driving product trial and education. We expect that as we continue to cultivate these relationships, brand awareness will increase, and we will be able to capture a significant share in an expanding market.
| 2 |
The Benefits of Hydrogen Infused Water
Water already has Hydrogen, as in H2O, but when those two hydrogen atoms are bound to oxygen, they are not available for any other interactions. When we infuse hydrogen gas into water, active hydrogen molecules are free and accessible to our body. Small and soluble, molecular hydrogen can quickly circulate and speed straight into the power centers of our cells. This interaction has been shown to increase athletic performance, reduce inflammation from exercise, and increase powerful antioxidants in our body. Our Reverse Osmosis filtering system ensures the purity and taste of our water, and our patented infusion process allows us to deliver PURE hydrogen and PURE water, and nothing else.
Our Products
The pouch. The pouch is unique, convenient to hold and carry, and plays a significant role in helping you reap all the benefits Hydrogen has to offer. The eco-conscious award-winning design and material was created in an effort to contain the additional Hydrogen in the water. When you add hydrogen to water, it tries to and usually does escape quite easily through more traditional materials such as plastic or glass Our pouch keeps the extra Hydrogen molecules contained and does so with a lower carbon footprint.
The can. Slim, sleek, and eye-catching, the HFactor cans are finished with a shiny white color so the blues and text information stand out on the shelf. Functionally, the aluminum material of the can is also very effective at containing extra Hydrogen molecules. HFactor was the pioneer in delivering still water in a recyclable aluminum can.
More Flavors.More Choices. While continuing meeting the demand for flavored hydrogen water with our existing portfolio-Watermelon, Honeydew and Tart Cherry, we launched a new flavor of Blackbeary and discontinued Blood Orange in 2022 to better serve our loyal customers with their preferred flavors. While utilizing natural flavors with no sugar or calories, these options offer consumers a great-tasting beverage that still provides the health benefits of our standard hydrogen-infused water.
| 3 |
Our Business Plan
HFactor's demonstrated efficacy, innovative packaging, and low carbon footprint has propelled traction since our launch in May 2017. Demand for multi-purpose functional beverages and a strong multi-channel sales strategy is driving HFactor's national reach. HFactor is a leader in the newly defined category of Functional Beverages and is well positioned as a business to maintain its competitive advantage in a new and growing space.
Our business plan focuses on four key areas: (1) regional focus; (2) retailer focus; (3) driving volume; and (4) controlling spending. We plan to focus on key regions of the US where our market traction is already established, including the Northeast, West Coast, Texas, and Florida. We also plan to aggressively cultivate the relationships we have with large retailers, including Walmart, Sprouts, Albertsons, Stop & Shop, and others. As we work towards these goals, we will strive to drive volume without losing sight of profitability as our main goal. We believe that as we focus on these four areas at once, we will be able to achieve sustained growth of the Company without compromising our profitability or the results of our operations.
ITEM 1A. RISK FACTORS
We are a "smaller reporting company", as defined in Item 10(f)(1) of Regulation S-K, and therefore are not required to provide the information specified in Item 1A.
ITEM 1B. UNRESOLVED STAFF COMMENTS
None.
ITEM 2. PROPERTIES
As a result of the COVID-19 pandemic, HFactor leadership and sales teams work remotely. Our manufacturing is maintained in Michigan City, Indiana and distribution is facilitated by a host of partner 3PL service providers. Leadership has successfully implemented effective and efficient communication and management processes that has established a remote structure that will be in place indefinitely.
ITEM 3. LEGAL PROCEEDINGS
We are not presently a party to any legal or regulatory proceedings that in the opinion of our management, if determined adversely to us, would individually or taken together have a material adverse effect on our business, results of operations and financial condition.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
| 4 |
PART II
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information
Our common stock is traded on the Pink Tier of the OTC Markets Group under the symbol "HWTR".
Holders of Record
As of December 31, 2022, there were 49,766,164 shares of Common Stock outstanding held by 196 holders of record.
Dividends
The Company does not expect to declare dividends for holders of Common Stock in the foreseeable future. Dividends will be declared, if at all (and subject to rights of holders of additional classes of securities, if any), in the discretion of the Company's Board of Directors. Dividends, if ever declared, may be paid in cash, in property, or in shares of the capital stock of the Company, subject to the provisions of law, the Company's Bylaws and the Certificate of Incorporation. Before payment of any dividend, there may be set aside out of any funds of the Company available for dividends such sums as the Board of Directors, in its absolute discretion, deems proper as a reserve for working capital, to meet contingencies, for equalizing dividends, for repairing or maintaining any property of the Company, or for such other purposes as the Board of Directors shall deem in the best interests of the Company.
Recent Sales of Unregistered Securities
We did not have any sales of unregistered equity securities during the year ended December 31, 2022 other than those that have been previously reported.
Use of Proceeds
None.
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
None.
ITEM 6. [Reserved]
| 5 |
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
You should read the following discussion and analysis of our financial condition and results of operations together with the section entitled “Selected Financial Data” and our financial statements and related notes included elsewhere in this Registration Statement. Some of the information contained in this discussion and analysis or set forth elsewhere in this Registration Statement, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. See “Cautionary Note Regarding Forward-Looking Statements.” Our actual results may differ materially from those described below.
We define our accounting periods as follows: “fiscal 2022” – January 1, 2022 through December 31, 2022.
This Management’s Discussion and Analysis (“MD&A”) reports on the operating results and financial condition of the Company for the years ended December 31, 2022 and December 31, 2021. The MD&A should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31, 2022 (“Annual Financial Statements”).
The MD&A and Annual Financial Statements have been prepared in accordance with general accepted principles in the United States of America (“GAAP”).
All significant intercompany balances and transactions were eliminated on consolidation.
Company History and Summary
HFactor, Inc., formerly known as Ficaar, Inc. (the “Company” or “HFactor” or “Ficaar”) was incorporated in July 2001 in the State of Georgia under the name OwnerTel, Inc. The name of the Company was changed to Ficaar, Inc. in December of 2007 and to HFactor, Inc. on September 2, 2021.
The Company’s fiscal year end is December 31.
On May 28, 2021, David Cicalese (“Cicalese”), an officer and Board member of Ficaar entered into an agreement with Gail Levy whereby Cicalese agreed to sell 29,900,000 shares, representing a majority interest in Ficaar, to Levy. Acting as the majority shareholder of the Company, Levy then caused Ficaar to enter into an Agreement and Plan of Merger (the "Merger Agreement") between the Company, FCAA Merger Sub I, Inc. ("Merger Sub"), a Delaware corporation and wholly owned subsidiary of Ficaar, and HyEdge, Inc. ("Target" or "HyEdge"), a Delaware corporation, wherein Merger Sub and Target would merge, with Target surviving the transaction as a wholly owned subsidiary of Ficaar (the "Merger"). The Merger Agreement was executed on August 6, 2021, and the Merger closed on August 9, 2021. The Merger effected a change in control and was accounted for as a "reverse acquisition" whereby Target is the accounting acquiror for financial statement purposes. Accordingly, for all periods subsequent to the Closing Date, the financial statements of the Company reflect the historical financial statements of HyEdge and any operations of the Company subsequent to the Merger.
Plan of Operations
BUSINESS DESCRIPTION
Immediately following the Merger executed on August 6, 2021, the business of HyEdge became our business. HyEdge was created by Gail Levy, HyEdge's founder and CEO. Gail is a successful serial entrepreneur who was looking for a new product that could alleviate the toxic side effects of the cancer chemotherapeutic drugs that had riddled a dear friend. As she researched the properties of hydrogen water, she became more and more enthralled by its potential. Ms. Levy felt she could honor her friend by making hydrogen water immaculate, effective, and accessible to everyone. Enlivened by this mission, she collected a team of experts to help her engineer a natural process to combine hydrogen with water with zero impurities and optimal impact. In 2017, she launched her flagship product through retail and ecommerce channels. HFactor was developed and is manufactured by a team of experts in the U.S. and utilizes a patented chemical-free and magnesium-free process to infuse free hydrogen into its water. Its award winning, environmentally friendly ergonomic pouch keeps the hydrogen potent and pure and makes it extremely portable.
| 6 |
HFactor's anti-inflammatory and antioxidant benefits appeal to a wide population across every age group, positioning HFactor to capture a significant share in an expanding market. The global market for bottled water is projected to reach $215B by 2025. HFactor has demonstrated significant market traction, with $2.87M sales in 2020, 30M+ followers across Social Media channels.
The quality of our product is achieved through a proprietary manufacturing process. A reverse osmosis filtering system and patent-protected infusion process ensures efficacy, purity, and taste. The efficacy of hydrogen water is backed by over 1,000 published peer reviewed studies demonstrating that hydrogen positively impacts fitness, health, lifestyle, recovery, and wellness.
Our sales strategy involves a diversified, multi-channel approach. Our products are currently on shelves in approximately 5,000+ retail stores across 20 chains in addition to our growing e-commerce presence. Our company prides itself on having a low carbon footprint due to our eco-conscious packaging.
Our mission statement is to build a brand and corporate culture that, at its essence, exhibits strength in oneself and in one's community. We promote a foundation of "doing well by doing good". This foundation enables HFactor to produce and distribute the highest quality "better for you" consumer products that are conscious to the community, mind, body, and the environment.
Comparison of Year Ended December 31, 2022 to Year Ended December 31, 2021
Results of Operations
| Year ended December 31, | Percent | |||||||||||||||
| 2022 | 2021 | Change | Change | |||||||||||||
| Revenues | $ | 1,886,666 | $ | 751,773 | $ | 1,134,893 | 151% | |||||||||
| Gross profit | 985,044 | 331,573 | 653,471 | 197% | ||||||||||||
| Operating expenses | 2,876,482 | 1,119,227 | 1,757,255 | 157% | ||||||||||||
| Other expenses | 530,055 | 805,038 | (274,983 | ) | (34% | ) | ||||||||||
| Net loss | $ | (2,421,493 | ) | $ | (1,592,693 | ) | $ | (828,800 | ) | 52% | ||||||
Net revenues for the year ended December 31, 2022 were $1,886,666, as compared to $751,773 for the year ended December 31, 2021, due to partial inclusion of the HyEdge revenue in 2021 as a result of the merger of this company.
Gross profits for the year ended December 31, 2022 were $ 985,044, as compared to $ 331,573 for the year ended December 31, 2021.
Total operating expenses were $ 2,876,482 for the year ended December 31, 2022, compared to $1,119,227 for the year ended December 31, 2021. The 157% increase was primarily attributable to the additional operating expenses, compared to the partial inclusion of the operation expenses of HyEdge in 2021 as the result of the merger. This increase is specifically reflected in $1,143,096 in sales and marketing expenses and $465,698 in general and administrative expenses.
Other expenses were $530,055 for the year ended December 31, 2022 compared to $805,038 for the year ended December 31, 2021. The decrease was primarily due to $300,203 in change in amortization of debt discount and derivative expenses associated with embedded liabilities in convertible debt.
For the year ended December 31, 2022, the Company reported a net loss of $2,421,493, as compared to a net loss of $1,592,693 for the year ended December 31, 2021. The $828,800 increase in net loss for the year ended December 31, 2022 mainly arose from the additional net loss resulting from the merger of HyEdge.
| 7 |
Liquidity and Capital Resources
As of December 31, 2022, the Company had $148,055 in cash to fund its operations. The Company reported working capital deficit of $ 5,260,943 on December 31, 2022, as compared to a working capital deficit of $ 4,695,836 on December 31, 2021, representing a increase in working capital deficit by $565,107.
The Company does not believe its current cash balance will be sufficient to allow the Company to fund its planned operating activities for the next twelve months. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations or substantially curtail some of its planned activities. These conditions raise substantial doubt as to the Company's ability to continue as a going concern. The accompanying financial statements do not include any adjustments relating to the recoverability and classification of recorded assets and classification of liabilities should the Company be unable to continue as a going concern.
As the Company continues to incur losses, achieving profitability is dependent on achieving a level of revenues adequate to support the Company's cost structure. The Company may never achieve profitability, and unless and until it does, the Company will continue to need to raise additional capital. Management intends to fund future operations through additional private or public equity offerings and may seek additional capital through arrangements with strategic partners from other sources. There can be no assurances, however, that additional funding will be available on terms acceptable to the Company, or at all. Any equity financing may be dilutive to existing shareholders.
Operating Activities:
For the year ended December 31, 2022, net cash flow used by operating activities was $1,763,799, compared to $ 826,956 for the year ended December 31, 2021. The increases in cash flow used for operating activities for both periods were primarily due to increases in operating expenditure.
Investing and Financing Activities:
Net cash flows provided by investing and financing activities for the year ended December 31, 2022, were $1,661,000, of which $1,420,000 was from sales of common stock shares and $241,000 in proceeds from borrowings, compared to $1,077,810 for the year ended December 31, 2021.
Liquidity and Capital Resource Measures:
The Company’s primary source of liquidity has been convertible loans and third party and related party loans.
Going Concern
The Company has experienced a net loss and had an accumulated deficit of $ 4,195,601 as of December 31, 2022. The success of our business plan during the next 12 months and beyond will be contingent upon generating sufficient revenue to cover our costs of operations and/or upon obtaining additional financing.
Transaction with Related Parties:
Parties are considered to be related if one party has the ability to control or exercise significant influence over the other party in making financial and operating decisions. Refer to Note 13 for details of transactions between the Company and related parties.
| 8 |
Critical Accounting Policies
Refer to Note 2 in the Consolidated Financial Statements for a summary of recently adopted and recently issued accounting standards and their related effects or anticipated effects on our consolidated results of operations and financial condition.
Off-Balance Sheet Arrangements
We did not have any off-balance sheet arrangements that are reasonably likely to have a current or future material effect on our financial condition, revenue or expenses, results of operations, liquidity, capital expenditure or capital resources.
Inflation and Changing Prices
We do not believe that inflation nor changing prices for the year ended December 31, 2022 had a material effect on our operations.
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are a "smaller reporting company", as defined in Item 10(f)(1) of Regulation S-K, and therefore are not required to provide the information specified in Item 7A.
| 9 |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Index to Consolidated Financial Statements
| 10 |
Report of Independent Registered Public Accounting Firm
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the shareholders and the board of directors of HFactor Inc.
Opinion on the Financial Statements
We have audited the accompanying balance sheet of HFactor Inc. (the “Company”) as of December 31, 2022 and the related statement of income, stockholders’ equity, and cash flow, for the period ended December 31, 2022 and the related notes and schedules (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022, and the results of its operations and its cash flows for year ended December 31, 2022 in conformity with generally accepted accounting principles in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have nor were we engaged to perform an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Going Concern
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has not established a source of revenue sufficient to cover its operating costs. As of December 31, 2022, the Company does not have sufficient working capital and cash resources to meet its planned business objectives. These and other factors raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plan regarding these matters is also described in Note 2 to the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
/s/
We have served as the Company’s auditor since 2021.
April 13, 2023
Bolko & Company
Certified Public Accountant
| F-1 |
HFACTOR, INC.
Condensed Consolidated Balance Sheets
| December 31, | December 31, | |||||||
| 2022 | 2021 | |||||||
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | $ | $ | ||||||
| Accounts receivable, net of allowance for doubtful accounts | ||||||||
| Inventories | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Total Current Assets | ||||||||
| Fixed Assets, net of accumulated depreciation | ||||||||
| Intangible Asset, net of accumulated amortization | ||||||||
| Total Assets | $ | $ | ||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued expenses | $ | $ | ||||||
| Accrued Interest | ||||||||
| Current portion of notes payable-third party, net of debt discount | ||||||||
| Notes payable and other payables-related party | ||||||||
| Derivative liabilities | ||||||||
| Warrant liability, net of unamortized discount | ||||||||
| Total Current Liabilities | ||||||||
| Long-Term Liabilities | ||||||||
| Government loans payable | ||||||||
| Note payable - Related party | ||||||||
| Total Long-Term Liabilities | ||||||||
| Total Liabilities | ||||||||
| Commitments and Contingencies | ||||||||
| Stockholders' Deficit | ||||||||
| Preferred stock , $ par value shares authorized, shares issued and outstanding as follows: | ||||||||
| Series C voting, convertible Preferred stock, $ par value shares authorized; shares issued and outstanding on December 31, 2022 and December 31, 2021, respectively | ||||||||
| Series D non-voting, convertible Preferred stock, $ par value shares authorized; and shares issued and outstanding on December 31, 2022 and December 31, 2021, respectively | ||||||||
| Common stock , $ par value shares authorized; and shares issued and outstanding on December 31, 2022 and December 31, 2021, respectively | ||||||||
| Common stock subscribed, and shares issued and outstanding on December 31, 2022 and December 31, 2021, respectively | ||||||||
| Additional paid-in capital | ( | ) | ( | ) | ||||
| Accumulated deficit | ( | ) | ( | ) | ||||
| Total Stockholders' Deficit | ( | ) | ( | ) | ||||
| Total Liabilities and Stockholders' Deficit | $ | $ | ||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
| F-2 |
HFACTOR, INC.
Condensed Consolidated Statements of Operations
Year Ended | Year Ended | |||||||
| December 31, | December 31, | |||||||
| 2022 | 2021 | |||||||
| REVENUES | ||||||||
| Sales, net | $ | $ | ||||||
| TOTAL REVENUES | ||||||||
| COST OF REVENUES | ||||||||
| GROSS PROFIT | ||||||||
| OPERATING EXPENSES | ||||||||
| Manufacturing expenses | ||||||||
| Sales and marketing | ||||||||
| General and administrative | ||||||||
| Total expenses | ||||||||
| Loss from operations | ( | ) | ( | ) | ||||
| Other (income) expense | ||||||||
| Amortization of debt discount | ||||||||
| Derivative (income) expense | ( | ) | ||||||
| Change in FMV of derivatives | ||||||||
| Interest expense | ||||||||
| Gain on forgiveness of debt | ( | ) | ||||||
| Other income | ( | ) | ( | ) | ||||
| Total Other (income) expense | ||||||||
| Net Loss | $ | ( | ) | $ | ( | ) | ||
| Net Loss per common shares outstanding- Basic and diluted: | ||||||||
| Net Loss per share attributable to common stockholders | $ | ) | $ | ) | ||||
| Weighted average shares outstanding | ||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
| F-3 |
HFACTOR, Inc.
Consolidated Statements of Stockholders' Deficit
| Series C | Series D | Common Stock | Additional | ||||||||||||||||||||||||||||||
| Preferred Stock | Preferred Stock | Common stock | Subscribed | Paid-In | Accumulated | ||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Capital | Deficit | Total | |||||||||||||||||||||||
| Balance as of December 31, 2020 | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||||||||||||||||||
| Merger of HyEdge, Inc. | – | ( | ) | ( | ) | ||||||||||||||||||||||||||||
| Sale of common shares | – | – | $ | ||||||||||||||||||||||||||||||
| Cancellation of shares | – | – | ( | ( | ) | – | ( | ) | |||||||||||||||||||||||||
| Net loss for the year ended December 31, 2021 | – | – | – | – | ( | ) | ( | ) | |||||||||||||||||||||||||
| Balance as of December 31, 2021 | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||||||||||||||||||
| Sale of common shares | – | $ | – | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Issuance of preferred and common subscribed shares | – | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||||
| Cancellation of shares | – | – | ( | ) | ( | ) | – | ||||||||||||||||||||||||||
| Cancellation of warrants in exchange for preferred stock | – | – | – | ||||||||||||||||||||||||||||||
| Shares issued for purchase of Intellectual Property | – | – | – | ||||||||||||||||||||||||||||||
| Net loss for the year ended December 31, 2022 | – | – | – | – | ( | ) | ( | ) | |||||||||||||||||||||||||
| Balance as of December 31, 2022 | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||||||||||||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
| F-4 |
HFACTOR, INC.
Condensed Consolidated Statements of Cash Flows
| Year Ended | Year Ended | |||||||
| December 31, | December 31, | |||||||
| 2022 | 2021 | |||||||
| OPERATING ACTIVITIES: | ||||||||
| Net loss | $ | ( | ) | $ | ( | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation | ||||||||
| Amortization of debt discount on convertible notes | ||||||||
| Derivative expense (income) | ( | ) | ||||||
| Change in fair market value of derivative liabilities | ||||||||
| Gain on forgiveness of debt | ( | ) | ||||||
| Other income | ( | ) | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | ( | ) | ||||||
| Inventory | ( | ) | ||||||
| Prepaid expenses | ( | ) | ( | ) | ||||
| Accounts payable and accrued expenses | ( | ) | ||||||
| Accrued interest | ||||||||
| NET CASH (USED) IN OPERATING ACTIVITIES | ( | ) | ( | ) | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
| Equipment purchase | ||||||||
| NET CASH (USED) IN INVESTING ACTIVITIES | ||||||||
| FINANCING ACTIVITIES: | ||||||||
| Sales of common stock | ||||||||
| Proceeds from convertible notes payable | ||||||||
| Proceeds from Loans Payable, related Party | ( | ) | ||||||
| NET CASH PROVIDED BY FINANCING ACTIVITIES | ||||||||
| Increase (decrease) in cash and cash equivalents | ( | ) | ||||||
| Cash and cash equivalents - Beginning | ||||||||
| Cash and cash equivalents - Ending | $ | $ | ||||||
| Supplemental Disclosure of Cash Flow Information | ||||||||
| Cash paid for interest | $ | $ | ||||||
| Cash paid for income taxes | ||||||||
| NON-CASH TRANSACTIONS: | ||||||||
| Common stock and Preferred stock issued in merger in exchange for net assets of HyEdge, Inc. | $ | $ | ( | ) | ||||
| Preferred stock issued in exchange for cancellation of Warrant Liabilities, net of unamortized discount | $ | $ | ||||||
| Common stock subscribed in exchange for assignment of Intellectual Property | $ | $ | ||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
| F-5 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 - DESCRIPTION OF BUSINESS
History
HFactor, Inc. formerly known as Ficaar, Inc. (the “Company” or “Ficaar” or “HFactor”) was incorporated in July 2001 under the name OwnerTel, Inc. The name of the Company was changed to Ficaar, Inc. in December of 2007 and to HFactor, Inc. on November 8, 2021.
On May 28, 2021, David Cicalese (“Cicalese”), an officer and Board member of Ficaar entered into an agreement with Gail Levy whereby Cicalese agreed to sell 29,900,000 shares, representing a majority interest in Ficaar, to Levy. Acting as the majority shareholder of the Company, Levy then caused Ficaar to enter into an Agreement and Plan of Merger (the “Merger Agreement”) between the Company, FCAA Merger Sub I, Inc. (“Merger Sub”), a Delaware corporation and wholly owned subsidiary of Ficaar, and HyEdge, Inc. (“Target” or “HyEdge”), a Delaware corporation, wherein Merger Sub and Target would merge, with Target surviving the transaction as a wholly owned subsidiary of Ficaar (the “Merger”). The Merger Agreement was executed on August 6, 2021, and the Merger closed on August 9, 2021. The Merger effected a change in control and was accounted for as a "reverse acquisition" whereby Target is the accounting acquiror for financial statement purposes. Accordingly, for all periods subsequent to the Closing Date, the financial statements of the Company reflect the historical financial statements of HyEdge and any operations of the Company subsequent to the Merger.
Immediately following the Merger, the business of HyEdge became the business of the Company.
In connection with the reverse acquisition and recapitalization, all share and per share amounts have been retroactively restated. Since the transaction is considered a reverse acquisition and recapitalization, accounting guidance does not apply for the purposes of presenting pro-forma financial information.
On September 2, 2021, the Company filed an amendment in its articles of incorporation to change its name to HFactor Inc. The Company was able to secure an OTC Bulletin Board symbol HWTR from Financial Industry Regulatory Authority (FINRA).
Present Operations
The Company, through its wholly owned subsidiary, HyEdge, Inc., a Delaware Corporation, engages in the manufacturing, marketing, distribution and selling of HFactor® hydrogen infused drinking water.
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation and Basis of Presentation
These consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States (“GAAP”) and are expressed in United States dollars. These consolidated financial statements include the accounts of HFactor Inc. and its wholly owned subsidiaries, HyEdge, Inc., a Delaware corporation and, the following all of which are inactive, Standard Canna, Inc., a Florida corporation, and its wholly owned subsidiaries, Standard Cultivation Systems Inc., a Colorado corporation; and Standard Property Group Inc., a California corporation; and as well as Precious Holdings, Inc., a Delaware corporation. All inter-company balances and transactions have been eliminated on consolidation.
| F-6 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Going Concern
The financial statements have been prepared on a going concern basis, and do not reflect any adjustments related to the uncertainty surrounding the Company’s recurring losses, working capital deficiency or accumulated deficit.
As of December 31, 2022, the Company had $
It is the Company’s intent to continue to raise funds in this manner and to raise funds through the sale of equity securities until the Company attains profitability. However, management cannot provide any assurance that the Company will be successful in accomplishing any of its plans.
The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plan described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
Cash
For the purpose of reporting cash flows,
the Company considers all short-term investments with an original maturity of three months or less when purchased to be cash
equivalents. As of December 31, 2022 and December 31, 2021, the Company held a cash balance of $
Revenue Recognition
Revenue from sales of the Company’s products is recorded when title and risk of loss have passed to the buyer and criteria for revenue recognition is met. The Company sells its products to individual consumers and resellers upon receipt of a written order. The Company has a limited return policy for defective items that requires that buyers give the Company notice within 30 days after receipt of the products. Due to the immaterial quantities of returned products historically, for the periods ended December 31, 2022 and December 31, 2021, the Company recognized revenue at the time of delivery without providing any reserve.
Accounts Receivable
Accounts receivable represent amounts due from
the Company’s customers. The Company maintains an allowance for doubtful accounts for estimated losses inherent in its accounts
receivable portfolio. In establishing the required allowance, management utilizes a specific customer identification methodology. Management
also considers historical losses adjusted for current market conditions and the customers’ financial condition and the current receivables
aging and current payment patterns. Account balances are charged off against the allowance after all means of collection have been exhausted
and the potential for recovery is considered remote. The Company does not have any off-balance sheet credit exposure related to its customers.
As of December 31, 2022 and December 31, 2021, the allowance for doubtful accounts was
| F-7 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Inventories
Inventories are stated at the lower of cost (on
a first-in, first-out basis) and market value. The stated cost is comprised of finished goods of HFactor® hydrogen infused
drinking water, its related raw material and spare parts for machinery. Reserves, if necessary, are recorded to reduce inventory to market
value based on assumptions about consumer demand, current inventory levels and product life cycles for the various inventory items. These
assumptions are evaluated annually and are based on the Company’s business plan and from feedback from customers and the product
development team. As of December 31, 2022 and 2021, the inventory reserves were
Fixed Assets
Fixed assets are stated at cost, less accumulated
depreciation. Depreciation is provided principally on the straight-line method over the estimated useful lives of the assets, which is
generally
The Company will periodically evaluate whether events and circumstances have occurred that may warrant revision of the estimated useful lives of fixed assets or whether the remaining balance of fixed assets should be evaluated for possible impairment. The Company uses an estimate of the related undiscounted cash flows over the remaining life of the fixed assets in measuring their recoverability.
Intangible Assets
On July 22, 2022, the Company entered into an
Intellectual Property Assignment Agreement, with Gail Levy whereby the Company acquired the intellectual property related to its beverage
production operations from HyEdge IP in exchange for shares of Company Common stock. The acquired intellectual property was valued
at $1.00 per share for total valuation of $
Advertising Costs
Advertising costs are expensed as incurred. Advertising
costs for the years ended December 31, 2022 and 2021 were $
Shipping and Handling
Costs incurred by the Company for shipping and
handling are included in costs of revenues. Shipping and handling costs for the years ended December 31, 2022 and 2021 were $
| F-8 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Income Taxes
The Company accounts for income taxes under ASC 740, Income Taxes. Under ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period, which includes the enactment date. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion of or all the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
ASC 740 contains a two-step approach to recognizing and measuring uncertain tax positions. This first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. The Company considers many factors when evaluating and estimating its tax positions and tax benefits, which may require periodic adjustments, and which may not accurately anticipate actual outcomes.
In June 2006, the Financial Accounting Standards Board issued FASB Interpretation No. 48 (FIN 48), “Accounting for Uncertainty in Income Taxes” - An interpretation of FASB Statement No. 109 and codified under ASC 740. FIN 48 clarifies the accounting for uncertainty in income taxes recognized in an entity’s financial statements in accordance with Statement of Financial Accounting Standards No. 109, “Accounting for Income Taxes”. This interpretation prescribed a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax provision taken or expected to be taken in a tax return. In addition, FIN 48 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosures and transition.
Based on its evaluation, the Company has concluded that there are no significant uncertain tax positions requiring recognition in its financial statements. The Company's evaluation was performed for the tax years ended December 31, 2017 through 2021, The Company does not expect any changes in its unrecognized tax benefits in the current year.
The Company’s policy for recording interest and penalties related to unrecognized tax benefits is to record such expenses as a component of current income tax expense. As of December 31, 2022 and 2021, the Company has no accrued interest or penalties related to uncertain tax positions.
Use of Estimates
The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.
| F-9 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Research and Development Expense
Costs related to research and development, which
primarily consists of consulting for logo and packaging design, are charged to expense as incurred. The Company has
The Company computes net income (loss) per share in accordance with ASC Topic 260, Earning per Share, formerly Statement of Accounting Standards SFAS No. 128, “Earnings per Share”, which requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) before and after discontinued operations, by the weighted average number of common shares outstanding (denominator) during the period, including contingently issuable shares where the contingency has been resolved. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. For the years ended December 31, 2022 and 2021, outstanding stock options, warrants, and shares issuable upon conversion of convertible notes were anti-dilutive because of net losses, and, as such, their effect has not been included in the calculation of diluted net loss per share.
The Company computes loss per common share, in accordance with FASB ASC Topic 260, Earnings Per Share, which requires dual presentation of basic and diluted earnings per share. Basic income or loss per common share is computed by dividing net income or loss by the weighted average number of common shares outstanding during the period. Diluted income or loss per common share is computed by dividing net income or loss by the weighted average number of common shares outstanding, plus the issuance of common shares, if dilutive, that could result from the exercise of outstanding stock options and warrants. No potential dilutive common shares are included in the computation of any diluted per share amount when a loss is reported.
Stock Based Compensation
The Company applies the fair value method of ASC 718, Compensation-Stock Compensation, in accounting for its stock-based compensation. These standards state that compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period, if any. The Company uses the Black-Scholes option pricing model to determine the fair value of its stock, stock option and warrant issuance. The determination of the fair value of stock-based payment awards on the date of grant using an option-pricing model is affected by the Company’s stock price, as well as assumptions regarding a few complex and subjective variables. These variables include the Company’s expected stock price, volatility over the term of the awards, actual employee exercise behaviors, risk-free interest rate and expected dividends.
Fair Value
FASB ASC 820, Fair Value Measurements and Disclosures (“ASC 820”) establishes a framework for all fair value measurements and expands disclosures related to fair value measurement and developments. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 requires that assets and liabilities measured at fair value are classified and disclosed in one of the following three categories:
| F-10 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Level 1 — Quoted market prices for identical assets or liabilities in active markets or observable inputs;
Level 2 — Significant other observable inputs that can be corroborated by observable market data; and
Level 3 — Significant unobservable inputs that cannot be corroborated by observable market data.
The carrying amounts of cash, loan receivable, accounts payable and other liabilities, and accrued interest payable approximate fair value because of the short-term nature of these items.
The fair value of the Company’s debt approximated the carrying value of the Company's debt as of December 31, 2022 and December 31, 2021. Factors that the Company considered when estimating the fair value of its debt included market conditions, liquidity levels in the private placement market, variability in pricing from multiple lenders and term of debt.
Recent Accounting Pronouncements
We have considered all other recently issued accounting pronouncements during 2022 and 2021 and do not believe the adoption of such pronouncements will have a material impact on our consolidated financial statements.
In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which will require lessees to recognize almost all leases on their balance sheet as a right-of-use asset and a lease liability. For income statement purposes, the FASB retained a dual model, requiring leases to be classified as either operating or finance. Classification will be based on criteria that are largely similar to those applied in current lease accounting, but without explicit bright lines. Lessor accounting is similar to the current model but updated to align with certain changes to the lessee model and the new revenue recognition standard. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. In January 2018, the FASB issued ASU 2018-01, which permits an entity to elect an optional transition practical expedient to not evaluate land easements that exist or expire before the Company's adoption of Topic 842 and that were not previously accounted for as leases under Topic 840. On May 20, 2020, the FASB voted to delay implementing the new lease standard for non-public organizations, making their new effective date the fiscal year starting after Dec. 15, 2021. The Company intends to elect this transition provision.
In August 2018, the FASB issued ASU 2018-13, “Changes to Disclosure Requirements for Fair Value Measurements”, which will improve the effectiveness of disclosure requirements for recurring and nonrecurring fair value measurements. The standard removes, modifies, and adds certain disclosure requirements, and is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019 (for “emerging growth company” beginning after December 15, 2020). The Company has adopted this standard effective from January 1, 2021, and the adoption of this standard did not have any significant impact on the consolidated financial statements.
| F-11 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
The FASB recently issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, to reduce complexity in applying GAAP to certain financial instruments with characteristics of liabilities and equity. The guidance in ASU 2020-06 simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt: Debt with Conversion and Other Options, which requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock. The guidance in ASC 470-20 applies to convertible instruments for which the embedded conversion features are not required to be bifurcated from the host contract and accounted for as derivatives. In addition, the amendments revise the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification. These amendments are expected to result in more freestanding financial instruments qualifying for equity classification (and, therefore, not accounted for as derivatives), as well as fewer embedded features requiring separate accounting from the host contract. The amendments in ASU 2020-06 further revise the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares. The amendments in ASU 2020-06 are effective for public entities for fiscal years beginning after December 15, 2021, with early adoption permitted (for “emerging growth company” beginning after December 15, 2023). The Company will be evaluating the impact this standard will have on the Company’s consolidated financial statements.
Update ASU 2021-10- Government Assistance (Topic 832)
In November 2021, the FASB issued guidance which requires business entities to disclose information about certain government assistance they receive. The amendments in this Update are effective for all entities within their scope for financial statements issued for annual periods beginning after December 15, 2021. Early application of the amendments is permitted. An entity should apply the amendments in this Update either (1) prospectively to all transactions within the scope of the amendments that are reflected in financial statements at the date of initial application and new transactions that are entered into after the date of initial application or (2) retrospectively to those transactions. We do not expect adoption of this standard to result in additional disclosures within our Consolidated Financial Statements.
NOTE 3 – FIXED ASSETS, NET
Fixed assets, net consist of the following:
| December 31, | December 31, | |||||||
| 2022 | 2021 | |||||||
| Machinery and equipment | $ | $ | ||||||
| Construction in progress | ||||||||
| Less accumulated depreciation | ( | ) | ( | ) | ||||
| Fixed assets net | $ | $ | ||||||
Depreciation expenses for the years ended December
31, 2022 and 2021 were $
| F-12 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 4 - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
Accounts payable amounting
to $
Accounts payable amounting
to $
NOTE 5 – GOVERNMENT DEBT
Paycheck Protection Program Loan
On April 20th, 2020, the Company executed
a note (the “PPP Note”) for the benefit of Stone Bank, N.A. (the “Lender”) in the aggregate amount of $
Economic Injury Disaster Loan
On June 2, 2020, the Company executed a
secured loan with the U.S. Small Business Administration (SBA) under the Economic Injury Disaster Loan program in the amount of
$
Future maturities of government debt are as follows:
| Year Ending December 31, | ||||
| 2023 | $ | |||
| 2024 | ||||
| 2025 | ||||
| 2026 | ||||
| Thereafter | ||||
Total Principal Payments | $ | |||
| F-13 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 6 – NOTES PAYABLE-THIRD PARTIES
Third party convertible notes payable consists of the following:
| December 31, 2022 | December 31, 2021 | |||||||
| Convertible promissory note with interest at | $ | $ | ||||||
| $ | ||||||||
| $ | ||||||||
| $ | ||||||||
| Unsecured promissory note for finder’s fee due with interest at | ||||||||
| Total Notes Payable-Third Parties | $ | $ | ||||||
(A) Includes a warrant for the right to purchase
an additional
| F-14 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 6 – NOTES PAYABLE-THIRD PARTIES (continued)
(B) Includes a warrant for the right to purchase
an additional
(C) Includes a warrant for the right to purchase
an additional
(D) On December 3, 2021, the Company entered into
a Stock Purchase Agreement with Boot Capital LLC (“Boot”), lender for the three notes of (A), (B) and (C), whereby Boot agreed
to retire all of its outstanding warrants (850,000 in total) in exchange for 200 shares of Series D Preferred stock. The Preferred stock
shares were issued on March 29, 2022. Accordingly, the Warrant liability of $
In accordance with ASC 470-20 “Debt
with Conversion and Other Options”, the Company allocated $-
| F-15 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 7 – NOTES PAYABLE - RELATED PARTY
Notes payable to related parties consists of the following:
| December 31, 2022 | December 31, 2021 | |||||||
| Secured Promissory Note – RP, dated September 30, 2019 Note accrues interest at 10 % per annum, due and payable on July 1, 2022 (Currently in default) (A) | $ | $ | ||||||
| Secured Promissory Note – LK, dated September 30, 2019 Note accrues interest at 10 % per annum, due and payable on July 1, 2022 (Currently in default) (A) | ||||||||
| Secured Promissory Note – C Lemen, dated July 23, 2020. Note accrues interest at 10% per annum, due and payable on July 1, 2022 (Currently in default) (A)(B) | ||||||||
| Unsecured Promissory Note – DC, dated September 30, 2012. Note accrues interest at 7% per annum, due and payable on June 30, 2022 (Currently in default) | ||||||||
| Total Notes Payable-Related Party | $ | $ | ||||||
| (A) |
| (B) |
NOTE 8 – DERIVATIVE LIABILITIES
The Company analyzed the notes payable – related parties and convertible notes payable referred to in Notes 6 and 7 based on the provisions of ASC 815-15 and determined that the conversion options of the convertible notes qualify as embedded derivatives and required the recognition of derivative liabilities.
For the derivative instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then revalued at each reporting date and any resulting gain or loss is recognized as a current period charge to the consolidated statements of operations. The Company estimates the fair value of the embedded derivatives using a Monte Carlo simulation valuation model that combines expected cash outflows with market-based assumptions regarding risk-adjusted yields, stock price volatility, probability of a change of control and the trading information of our common stock into which the notes are convertible, as appropriate to value the derivative instruments at inception and subsequent valuation dates and the value is reassessed at the end of each reporting period, in accordance with FASB ASC Topic 815-15.
The aggregate fair value of derivative liabilities as of December 31,
2022 and December 31, 2021 amounted to $
| F-16 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 8 – DERIVATIVE LIABILITIES (continued)
| Consolidated Balance Sheet | Quoted (Level 1) | Quoted (Level 2) | Significant (Level 3) | |||||||||||||
| Derivative Liabilities: | ||||||||||||||||
| December 31, 2022 | $ | $ | $ | $ | ||||||||||||
| December 31, 2021 | $ | $ | $ | $ | ||||||||||||
The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis:
Year Ended 2022 | Year Ended December 31, 2021 | |||||||
| Beginning balance | $ | $ | ||||||
| Aggregate fair value of conversion features upon issuance | ||||||||
| Fair value of derivatives reclassified to equity | ||||||||
| Net transfer into level 3 | ||||||||
| Fair value of warrants netted against common stock issued for stock | ||||||||
| Change in fair value of conversion features | ( | ) | ||||||
| Change in fair value of warrant and stock option derivative liabilities | ||||||||
| Ending balance | $ | $ | ||||||
NOTE 9 – MERGER AND RELATED TRANSACTIONS
The Merger
On August 6, 2021, the Company, FCAA Merger Sub I, Inc, (“Merger Sub”), a Delaware corporation and wholly owned subsidiary of Ficaar, and HyEdge, Inc. (“Target” or “HyEdge”), a Delaware corporation, entered into an Agreement and Plan of Merger (the “Merger Agreement”) which closed on August 9, 2021 (the "Closing Date"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Target and the separate corporate existence of Merger Sub ceased, with Target continuing its corporate existence as a wholly owned subsidiary of the Company. The Merger effected a change in control and was accounted for as a "reverse acquisition" whereby Target is the accounting acquiror for financial statement purposes. Accordingly, for all periods subsequent to the Closing Date, the financial statements of the Company reflect the historical financial statements of HyEdge and any operations of the Company subsequent to the Merger.
| F-17 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 9 – MERGER AND RELATED TRANSACTIONS (continued)
Prior to the Merger, the Company ceased being an operating company and became a “shell company”. Pursuant to the Merger, the Company acquired the business of Target to engage in the business of the development, marketing, and sale of hydrogen-infused water and other consumer goods.
As consideration for the merger, Target shareholders
exchanged 100% of Target Stock (as defined in the Merger Agreement) totaling 44,136,473 fully diluted shares into shares of Company Common
Stock at a conversion rate of
The end of report schedule presents unaudited consolidate pro forma results of operations data as if the acquisitions had occurred on January 1, 2020. This information does not purport to be indicative of the actual results that would have occurred if the acquisition had actually been completed on the date indicated, not is it necessarily indicative of the future operating results or the financial position of the combined company.
Changes to the Company's Officers and Directors
Effective May 27, 2021, the Company’s Board of Directors appointed Gail Levy as Chief Executive Officer of FICAAR, Inc. On June 1, 2021, in conjunction with the aforementioned change in control, David Cicalese resigned as Secretary and Chairman of the Board of Directors. On June 9, 2021, a majority of Company shareholders elected Gail Levy as Chairman and a member of the Board of Directors. These changes were reported on the Company's form 8-K that was filed on June 10, 2021.
In conjunction with the Merger, Dawn Cames resigned as President, James C. Sanborn was appointed as COO and as a member of the Board of Directors, and Leonard Klingbaum was appointed as a member of the Board of Directors.
On July 22, 2022, the Company entered into a
Memorandum of Understanding (“MOU”) with Bear Face Capital LLC (“Bear Face”) and Concorde Consulting Corp (“Concorde”)
for an influx of capital. In accordance with the terms of the MOU, the following changes were implemented: (i) Gail Levy resigned as
Chief Executive Officer and assumed the position of President for the Company, subject to a two (2) year Employment Contract, renewable
annually, at an annual salary of $
NOTE 10 – COMMITMENTS AND CONTINGENCIES
Legal – To the best of our knowledge and belief, no material legal proceedings of merit are currently pending or threatened.
Legal Matters:
From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm its business.
| F-18 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 10 – COMMITMENTS AND CONTINGENCIES (continued)
To the best of the Company’s knowledge and belief, no material legal proceedings of merit are currently pending or threatened.
Dispute:
The Company is disputing the validity of a convertible promissory note carried over from its merger in August 2021. Since it presently is not possible to determine the outcome of this matter, the note is disclosed in Note 4 to the financial statements with a net balance of $121,369 until its ultimate resolution.
Employment and Consulting Agreements:
Gail Levy resigned as Chief Executive Officer
and assumed the position of President for the Company, subject to a two (2) year Employment Contract, renewable annually, at an annual
salary of $
Rental:
As a result of the COVID-19 pandemic, Company management and employees have been working remotely and accordingly, incurring no rental expense during the years ended December 31 2022 and 2021.
COVID-19
In December 2019, a novel
strain of coronavirus (“COVID-19”) was reported to have surfaced in Wuhan, China, and has since reached multiple other countries,
including the United States, resulting in government-imposed quarantines, travel restrictions and other public health safety measures
in affected countries. The various precautionary measures taken by many governmental authorities around the world in order to limit the
spread of COVID-19has had, and could continue to have, an adverse effect on the global markets and its economy, including on the availability
and pricing of employees and resources, and other aspects of the global economy. Although the Company cannot predict the impact that the
COVID-19 pandemic will have on its business or results of operations in future periods, to date, the Company’s core water product
applications have been able to support the increased demand the Company has experienced. On April 20, 2020, to help ensure adequate liquidity
in light of the uncertainties posed by the COVID-19 pandemic, the Company entered into a promissory note with an aggregate principal
amount of $
On March 11, 2020, the World Health Organization declared the ongoing COVID-19 outbreak as a global health emergency. This resulted in governments worldwide enacting emergency measures to combat the spread of the virus, including the closure of certain non-essential businesses
During the years ended December 31, 2022 and 2021, respectively, the pandemic did not have a material impact on the Company’s operations. As of December 31, 2022 and 2021, the Company did not observe any material impairment of its assets or a significant change in the fair value of assets due to the COVID-19 pandemic. The Company has taken steps to minimize the potential impact of the pandemic including safety measures with respect to personal protective equipment, the reduction in travel and the implementation of a virtual office including regular video conference meetings and participation in virtual customer meetings and other virtual events.
| F-19 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 11 – EQUITY
Common stock:
The Company has authorized shares of $ par value common stock. As of December 31, 2022 and December 31, 2021, the Company had and shares, respectively, of common stock issued and outstanding.
On October 27, 2021 shares of Common Stock of the Company held by the Company’s Chief Executive Officer were returned to treasury and retired.
On December 10, 2021 and December 15, 2021, the Company received total
proceeds of $
On November 12, 2021, the U.S. Securities and Exchange Commission (“SEC”) issued a Notice of Qualification for the Company's Form 1-A Offering Circular for an offering of the Company’s Common Stock shares under Regulation A+ (the "Offering") of the Securities Act of 1933 (the “Act”). The purpose of the Offering is to allow both accredited and non-accredited potential investors the opportunity to invest directly in the Company. The Offering has a minimum and maximum investment of $25,000 to at a price of $1.00 per share.
During the first quarter
of 2022, the Company received total proceeds of $
During the second quarter
of 2022, the Company received total proceeds of $
During the third quarter
of 2022, the Company received total proceeds of $
During the four quarter of 2022, the Company
received total proceeds of $
Preferred Stock:
The Company has authorized 30,000,000 shares of $ par value preferred stock.
On August 6, 2021, the Company amended its Articles of Incorporation to include Certificates of Designation for two new classes of Preferred Stock – Series C Preferred, authorized shares and, Series D Preferred, authorized shares.
In connection with the Merger with HyEdge, on September 15, 2021, the Company issued shares of Series C Convertible Preferred stock, non-dividend, with voting rights. Each share of Series C Preferred stock is convertible into the number of shares of the Company’s common stock equal to the result of (i) 1.5 times the number of Common shares issued and outstanding calculated on a fully diluted basis at the time of conversion, (ii) divided by the total number of Series C Preferred shares issued and outstanding at the time of conversion.
| F-20 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 11 – EQUITY (continued)
Additionally, the Company issued shares of Series D Convertible Preferred stock, non-dividend, with no voting rights. Each share of Series D Preferred stock is convertible into the number of shares of the Company’s common stock equal to 0.01% of the number of Common shares issued and outstanding at the time of conversion.
On March 29,2022, shares of Series D Preferred Stock were issued to an investor in connection with execution of a Leak-Out Agreement.
On June 29, 2022, shares of Series D Preferred Stock were issued to an investor in connection with execution of a Leak-Out Agreements.
On November 22, 2022, , and shares of Series D Preferred Stock were issued to three investors in connection with execution of a Leak-Out Agreements.
As of December 31, 2022,
NOTE 12 – INCOME TAXES
The Company uses the liability method, where deferred tax assets and liabilities are determined based on the expected future tax consequences of temporary differences between the carrying amounts of assets and liabilities for financial and income tax reporting purposes. During the current period, the Company incurred a net loss and therefore has no tax liability.
The Company has U.S. federal and state net operating
loss carryovers (“NOL’s”) of approximately $
At December 31, 2022, the Company has a net operating
loss carryforward of approximately $
December 31, 2022 | December 31, 2021 | |||||||
| Deferred tax asset: | ||||||||
| Net operating loss carry-forward | $ | $ | ||||||
| Less: valuation allowance | ( | ) | ( | ) | ||||
| Net deferred income tax asset | $ | $ | ||||||
| F-21 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 12 – INCOME TAXES (CONTINUED)
The amount taken into income as deferred income tax assets must reflect that portion of the income tax loss carry forwards that is more-likely-than-not to be realized from future operations. The Company has chosen to provide a full valuation allowance against all available income tax loss carry forwards. The Company has recognized a valuation allowance for the deferred income tax asset since the Company cannot be assured that it is more likely than not that such benefit will be utilized in future years. The valuation allowance is reviewed annually. When circumstances change and which cause a change in management’s judgment about the realizability of deferred income tax assets, the impact of the change on the valuation allowance is generally reflected in current income.
As of December 31, 2022
and December 31, 2021, the Company has
NOTE 13 – RELATED PARTY TRANSACTIONS
Parties are considered to be related if one party has the ability to control or exercise significant influence over the other party in making financial and operating decisions. Details of transactions between the Company and related parties are disclosed below:
On April 15, 2019, HyEdge entered into an intellectual property licensing agreement (the “Agreement”) with HyEdge IP Co. (“HyEdge IP”), an entity 100% owned by the founder and CEO of HyEdge. Pursuant to the Agreement, HyEdge IP granted HyEdge an exclusive, non-assignable, non-sublicensable and royalty-free right and license to use the intellectual properties related to beverages infused with hydrogen for human consumption owned by HyEdge IP (the “Intellectual Properties”), solely within North America. In addition, HyEdge agrees to irrevocably assign and transfer to HyEdge IP all of its rights, title and interest in and to any improvements acquired through use, modification or improvement on the Intellectual Properties (the “Improvements”).
The license will be terminated if 1) HyEdge fails to perform any term or condition of the Agreement and fails to cure such failure within 30 days, HyEdge undergoes any direct or indirect sale, merger, consolidation, or transfer of greater than 50% of the Licensee's ownership shares or business assets to a person or group of persons, or 3) HyEdge substantially discontinues business operations.
On December 20, 2019, HyEdge and HyEdge IP entered into an amendment to the Agreement (the "Amendment"), expanding the territory in the Agreement from North America to worldwide, including the World Wide Web. In addition, the Amendment clarified the scope of the license and rights in question, which includes the Intellectual Properties and the Improvements. The Amendment also stipulated that HyEdge and HyEdge IP shall agree upon a royalty for HyEdge's use of the Intellectual Properties, including the Improvements, outside of North America.
On July 22, 2022, the Company entered into an
Intellectual Property Assignment Agreement with Gail Levy, whereby the Company acquired the intellectual property related to its beverage
production operations from HyEdge IP in exchange for shares of Company Common stock. The acquired intellectual property was valued
at $ per share for total valuation of $
During the third and fourth quarters of 2022,
the Company received funds, totaling $
| F-22 |
HFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 14 – SUBSEQUENT EVENTS
The Company has evaluated subsequent events through March 31, 2023, which is the date the financial statements were issued, and has concluded that no such events or transactions took place which would require adjustment to or disclosure in the financial statements, except for the following:
Equity
During the first quarter of 2023, the Company issued 701,250 shares of Company Common Stock to Divario Ventures LLC, as part of the Incentive Equity Payment, pursuant to the Product Placement Agreement dated August 22, 2018.
| F-23 |
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.
None.
ITEM 9A. CONTROLS AND PROCEDURES
We are a "smaller reporting company" as defined in Item 10(f)(1) of Regulation S-K, and are a non-accelerated filer, and therefore are not required to provide the information specified in Item 9A.
ITEM 9B. OTHER INFORMATION
[None]
ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
Not applicable.
| 11 |
PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE
Below are the names of and certain information regarding the Company's current executive officers and directors:
|
Name |
Position |
Date of Appointment | ||
| Dawn Cames | Director, Chairman of the Board |
July 2022 | ||
| Gail Levy | President | July 2021 |
The following are brief biographies of the officers and directors:
Dawn Cames, 54, Director and Chairman of the Board
Dawn Cames is an automotive executive with 32 years in the luxury automotive business. Since October 2022 Ms. Cames has taken on the role of General Manager at Autosport Designs, Inc, a vintage and exotic Automotive Dealership with a worldwide clientele of automotive enthusiasts. From 2007 to 2022, Ms. Cames served as General Manager for JLR Long Island. From 1992 to 2006, Ms. Cames was a Sales Manager for the Long Island Automotive Group. Throughout her career, Ms. Cames has worked with her teams to drive common processes, business results and customer loyalty. Her experience working with national marketing boards has helped Dawn launch new product lines in the very competitive automotive market.
Gail Levy, 67, President
Gail Levy, Founder and CEO of HFACTOR since 2014. Ms. Levy is a serial entrepreneur who has had success in traditional brick and mortar retail market with industry leaders such as Home Depot, Lowes, Sears, and Kmart, among others. As an early adopter of eCommerce Ms. Levy created a design and fulfillment company of home décor, gifts, and outdoor lifestyle products that became resources for commercial giants such as 1-800 Flowers, FTD, Pro Flowers, Hallmark, and Garden.com. Ms. Levy then transferred her start-up prowess to designing fashion hard goods for celebrity notables such as Martha Stewart, Katie Brown, Jaclyn Smith, and Christopher Lowell in the tabletop, home and office décor, and garden industries. Ms. Levy’s work has been featured in numerous trade publications, as well as on Oprah, CBS, and NBC.
Board of Directors
Our board of directors currently consists of one director, who is not "independent" as defined in Rule 4200 of FINRA's listing standards. We may appoint additional independent directors to our board of directors in the future, particularly to serve on committees should they be established.
Committees of the Board of Directors
We may establish an audit committee, compensation committee, a nominating and governance committee and other committees to our Board of Directors in the future but have not done so as of the date of this Offering Circular. Until such committees are established, matters that would otherwise be addressed by such committees will be acted upon by the Board of Directors.
| 12 |
Director Compensation
The Company currently does not pay any cash compensation to members of its board of directors for their services as directors of the Company. However, the Company reimburses its directors for all reasonable out-of-pocket expenses incurred in connection with their attendance at meetings of the board of directors. The Company may determine to grant to each new director, at the time of such director's appointment, an option to purchase its common shares. In the future, the Company may also elect to offer directors cash compensation.
Limitation of Liability and Indemnification of Officers and Directors
Our Bylaws limit the liability of directors and officers of the Company to the maximum extent permitted by Georgia law. The Bylaws state that the Company shall indemnify and hold harmless each person who was or is a party or is threatened to be made a party to, or is otherwise involved in any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that such person is or was a director or an officer of the Company or such director or officer is or was serving at the request of the Company as a director, officer, partner, member, manager, trustee, employee or agent of another company or of a partnership, limited liability company, joint venture, trust or other enterprise.
The Company believes that indemnification under our Bylaws covers at least negligence and gross negligence on the part of indemnified parties. The Company also may secure insurance on behalf of any officer, director, employee, or other agent for any liability arising out of his or her actions in connection with their services to us, regardless of whether our Bylaws permit such indemnification.
The Company may also enter into separate indemnification agreements with its directors and officers, in addition to the indemnification provided for in our Bylaws. These agreements, among other things, may provide that we will indemnify our directors and officers for certain expenses (including attorneys' fees), judgments, fines and settlement amounts incurred by a director or executive officer in any action or proceeding arising out of such person's services as one of our directors or officers, or rendering services at our request, to any of its subsidiaries or any other company or enterprise. We believe that these provisions and agreements are necessary to attract and retain qualified people as directors and officers.
There is no pending litigation or proceeding involving any of our directors or officers as to which indemnification is required or permitted, and we are not aware of any threatened litigation or proceeding that may result in a claim for indemnification.
For additional information on indemnification and limitations on the liability of our directors and officers, please review the Company's Bylaws, which are attached to this Offering Circular.
| 13 |
ITEM 11. EXECUTIVE COMPENSATION
The following table sets forth for the two years ended December 31, 2022 and 2021, the compensation awarded to, paid to, or earned by, the Company's Chief Executive Officer, President, Secretary and Treasurer.
Summary Compensation Table
| Name & Principal Position | Fiscal Year ended December 31, |
Salary ($) | Bonus ($) | Stock Awards($) | Option Awards($) | Non-Equity Incentive Plan Compensation ($) | Non-Qualified Deferred Compensation Earnings ($) | All Other Compensation ($) | Total ($) | |||||||||
| Gail Levy, | 2022 | 120,000 | 0 | 0 | 0 | 0 | 0 | 0 | 120,000 | |||||||||
| President | 2021 | 75,000 | 0 | 0 | 0 | 0 | 0 | 0 | 75,000 | |||||||||
| Dawn Cames, | 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||
| Director & Chairman (1) | 2021 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||
| (1) | Dawn Cames was appointed as a Director and Chairman of the Board July 22, 2022. |
| 14 |
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The following table sets forth information regarding beneficial ownership of our Stock as of the date of this report.
|
Name and Position Address |
Class | Shares Owned | |||||
| Number | Percent | ||||||
|
Gail Levy, President 244 Madison Ave. #1249 New York, New York 10016 |
Common Stock Series D Preferred |
11,076,400 395 |
22.26% 9.083% |
||||
|
Dawn Cames, Director and Chairman of the Board Huntington Station, New York |
Common Stock Series C Preferred |
2,433,334 1 |
4.8% 100% |
||||
|
Enlightened Access Capital LLC (Beneficial Owner) New York, New York |
Common Stock | 2,513,022 | 5.05% | ||||
|
Divario Ventures LLC (Beneficial Owner) Boise, Idaho |
Common Stock | 3,105,055 | 6.23% | ||||
|
Christopher Vingiano (Beneficial Owner) Boynton Beach, Florida |
Common Stock | 3,000,000 | 6.02% | ||||
|
Nuno Beira (Beneficial Owner) Davie, Florida |
Common Stock | 3,000,000 | 6.02% | ||||
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
All related transactions have been reported in Part II Item 8 Financial Statements.
ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
| 2022 | 2021 | |||||||
| Audit Fees | $ | 13,500 | $ | 12,000 | ||||
| Audit Related Fees | – | – | ||||||
| Tax Fees | – | – | ||||||
| All Other Fees | ||||||||
| $ | 13,500 | $ | 12,000 | |||||
| 15 |
Audit Fees — This category includes the audit of our annual financial statements, review of financial statements included in our Quarterly Reports on Form 10-Q and services that are normally provided by the independent registered public accounting firm in connection with engagements for those fiscal years. This category also includes advice on audit and accounting matters that arose during, or as a result of, the audit or the review of interim financial statements.
Audit-Related Fees — This category consists of assurance and related services by the independent registered public accounting firm that are reasonably related to the performance of the audit or review of our financial statements and are not reported above under “Audit Fees.” The services for the fees disclosed under this category include consultation regarding our correspondence with the Securities and Exchange Commission, other accounting consulting and other audit services.
Tax Fees — This category consists of professional services rendered by our independent registered public accounting firm for tax compliance and tax advice. The services for the fees disclosed under this category include tax return preparation and technical tax advice.
Policy for Pre-Approval of Audit and Non-Audit Services
We have not established an audit committee. Our board of directors approved the services rendered and fees charged by our independent registered public accounting firm.
Our board of directors’ policy is to pre-approve all audit services and all non-audit services that our independent registered public accounting firm is permitted to perform for us under applicable federal securities regulations. As permitted by the applicable regulations, our board of directors’ policy utilizes a combination of specific pre-approval on a case-by-case basis of individual engagements of the independent registered public accounting firm.
All engagements of the independent registered public accounting firm to perform any audit services and non-audit services since that date have been pre-approved by our board of directors in accordance with the pre-approval policy. The policy has not been waived in any instance. All engagements of the independent registered public accounting firm to perform any audit services and non-audit services prior to the date the pre-approval policy was implemented were approved by our board of directors in accordance with its normal functions.
| 16 |
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
| 101.INS | Inline XBRL Instances Document | * | ||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | * | ||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | * | ||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | * | ||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | * | ||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | * | ||||||
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). | * |
| 17 |
SIGNATURES
Pursuant to the requirements of Section 13 or 15 of the Securities Exchange Act, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| HFactor, Inc. | ||
| (Registrant) | ||
| April 17, 2023 | By: | /s/ Dawn Cames |
| Dawn Cames | ||
| Principal Executive Officer & Acting Principal Financial Officer | ||
| 18 |